In order to avoid a similar situation to the one experienced a month and a half ago, the Costa Rican Social Security Fund (CCSS), has already begun the corresponding analysis that will allow you to determine if you can make an annual purchase of a medicine against Human Immunodeficiency Virus (HIV).
Efavirenz is used by about 5,000 patients, so it now seeks to purchase it through the Pan American Health Organization (PAHO), to ensure the supply of the product by 2018.
According to Manrique Cascante, head of Supply of Goods and Services, they are carrying out the administrative procedure against the company that failed to deliver it in July.
Faced with this situation and in order to guarantee the medicine to five thousand patients who use it, the CCSS had to borrow from other governments. At this moment they coordinate the payment to the Dominican Republic and El Salvador.
In addition to this, the institution explained that some 478 thousand tablets of Efavirenz entered the Laboratory of Standards and Quality of Medicines on Tuesday, in order to meet the needs.
Gabriela Murillo, logistics manager, explained that the tablets arrived in the country on Thursday and that same day they were transferred to the general store. As of today, they began the process of quality control that the institution performs to all the medicines that it acquires for the population.